Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons by Vincent, Andrea M. et al.
©2005 FASEB 
The FASEB Journal express article 10.1096/fj.04-2513fje. Published online January 27, 2005. 
Short-term hyperglycemia produces oxidative damage and 
apoptosis in neurons 
Andrea M. Vincent, Lisa L. McLean, Carey Backus, and Eva L. Feldman 
University of Michigan, Department of Neurology Ann Arbor, Michigan 48109 
Corresponding author: Andrea M. Vincent, Ph.D., University of Michigan, Department of 
Neurology, 4414 Kresge III, 200 Zina Pitcher Place, Ann Arbor, MI 48109. E-mail: 
andreav@umich.edu 
ABSTRACT 
Dorsal root ganglia neurons in culture die through programmed cell death when exposed to 
elevated glucose, providing an in vitro model system for the investigation of the mechanisms 
leading to diabetic neuropathy. This study examines the time course of programmed cell death 
induction, regulation of cellular antioxidant capacity, and the protective effects of antioxidants in 
neurons exposed to hyperglycemia. We demonstrate that the first 2 h of hyperglycemia are 
sufficient to induce oxidative stress and programmed cell death. Using fluorimetric analysis of 
reactive oxygen species (ROS) production, in vitro assays of antioxidant enzymes, and 
immunocytochemical assays of cell death, we demonstrate superoxide formation, inhibition of 
aconitase, and lipid peroxidation within 1 h of hyperglycemia. These are followed by caspase-3 
activation and DNA fragmentation. Antioxidant potential increases by 3–6 h but is insufficient to 
protect these neurons. Application of the antioxidant α-lipoic acid potently prevents glucose-
induced oxidative stress and cell death. This study identifies cellular therapeutic targets to 
prevent diabetic neuropathy. Since oxidative stress is a common feature of the micro- and 
macrovascular complications of diabetes, the present findings have broad application to the 
treatment of diabetic patients. 
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ur laboratory is focused on understanding the pathogenesis of microvascular 
complications of diabetes, with a focus on neuropathy (1). At present, improvement of 
glycemic control remains the only therapeutic strategy to prevent or delay the onset or 
progression of diabetic neuropathy (2). Hyperglycemia in animal and in vitro models of diabetes 
activates a number of enzymatic and nonenzymatic pathways of glucose metabolism that are 
implicated in the development of neuropathy. These include 1) increased polyol pathway activity 
leading to sorbitol and fructose accumulation, NAD(P)-redox imbalances, and changes in signal 
transduction; 2) nonenzymatic glycation of proteins yielding “advanced glycation end-products” 
(AGEs); 3) activation of protein kinase C (PKC), initiating a cascade of stress responses; 4) 
increased hexosamine pathway flux; and 5) hyperglycemia-mediated superoxide overproduction 
by the mitochondrial electron transfer chain (3–5). Each of these mechanisms result in reactive 
oxygen species (ROS), reflected in an overall increased state of cellular oxidative stress. 
O 
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Inhibition of ROS, as well as maintenance of euglycemia, may restore metabolic and vascular 
imbalances and block both the initiation and progression of neuropathy (3, 6). 
We have reported that apoptosis occurs in dorsal root ganglion (DRG) neurons and Schwann 
cells of diabetic rats. Approximately 30% of DRG from diabetic rats express cleaved capsase-3 
and are TUNEL positive (7). Electron microscopy demonstrates that DRG from diabetic animals 
contain swollen mitochondria with disrupted inner cristae structure (7). Our observations of 
apoptosis and loss of neurons in the DRG of diabetic animals agree with the findings of other 
laboratories (8–11). Free radicals are produced in DRG neurons exposed to hyperglycemia and 
parallel the development of mitochondrial dysfunction. After hyperglycemia, DRG neurons 
display mitochondrial membrane depolarization, release of mitochondrial cytochrome c, caspase 
activation, DNA degradation, and chromatin condensation (11, 12). 
We have also demonstrated that mitochondrial dysfunction and apoptosis seen in diabetic rats 
can be recapitulated in an in vitro cell culture model (7, 13). Examination of DRG neurons in 
culture permits the examination of pathologic and neuroprotective mechanisms that closely 
reflect the responses of neurons in the whole animal (14). Our in vitro approach allows us to ask 
and answer mechanistic questions that are not possible in animal models. The current study 
further explores the mechanisms underlying glucose-mediated cell death in DRG neurons in 
culture. We can then return to the animal model and perform genetic manipulations to test the 
relevance of these mechanisms in vivo. In the cell culture model, oxidative stress is evident 
within 2 h of hyperglycemia. The DRG neurons respond to glucose-mediated oxidative stress by 
maintaining glutathione levels and increasing the antioxidant enzymes superoxide dismutase 
(SOD) and catalase after 3 h. Yet, this response is insufficient; within 2 h of hyperglycemia, 
DRG neurons activate cell death pathways. In contrast, exogenous antioxidants α-lipoic acid and 
catalase together can prevent hyperglycemia-induced oxidative stress and cell death. Thus, rapid 
hyperglycemia-induced oxidative stress is a critical mediator of DRG neuron injury. The study 
strongly indicates the use of antioxidants in the prevention of diabetic neuropathy, as well as 
targeting secondary mechanisms of regulation of the innate antioxidant response and inhibition 
of hyperglycemia-induced NADH oxidase activity. 
MATERIALS AND METHODS 
DRG culture model of hyperglycemia 
DRG were harvested from embryonic day 15 Sprague-Dawley rats, dissociated in 1% trypsin, 
and then cultured on rat-tail collagen-coated culture plates in growth media. All culture reagents 
were from Gibco (Grand Island, NY) unless stated otherwise. Growth media was prepared using 
Neurobasal medium supplemented with 1× B-27 additives, 50 ng/ml NGF (Harlan Bioscience, 
Indianapolis, IN), 40 µM FUDR (Sigma, St Louis, MO), and 1,000 U/ml 
penicillin/streptomycin/neomycin (ABX) solution. Initial plating medium contains 2 µM 
glutamine. DRG neurons were re-fed after 24 h in fresh media containing all additives except 
glutamine. On day 2, cells were rinsed then re-fed using treatment media (neurobasal media 
containing 4 ng/ml selenium, 4 ng/ml hydrocortisone, 0.01 mg/ml transferrin, 3 ng/ml β-
estradiol, 50 ng/ml NGF, 40 µM FUDR, and ABX). Experiments were performed on DRG 
neurons on day 3 in culture in the absence of B-27 additives. Neurobasal medium contains a 
basal 25 mM glucose that was essential for DRG neuron culture (7). Previous studies 
Page 2 of 24
(page number not for citation purposes)
demonstrate that lower concentrations of glucose also induce DRG neuron death in culture and 
that hyperglycemic insult leading to DRG neuron death was produced at greater than 35 mM 
total glucose (7). To produce a hyperglycemic insult, 20 mM additional glucose (yielding a total 
45 mM glucose) was added to the media for the period specified in individual experiments. 
Media glucose concentrations do not significantly decrease during the treatment periods as 
determined by mass spectrometry. 
Antioxidant treatment of DRG neurons 
α-Lipoic acid is a potent antioxidant that is in clinical trials for diabetic neuropathy (15, 16). 
Many reagents, when dissolved in growth media, release hydrogen peroxide (17). This can 
confound the study of their protective effects in cell culture by producing a pro-oxidant effect. 
Catalase is an enzyme that breaks down hydrogen peroxide, and so the freshly dissolved α-lipoic 
acid was treated with catalase to remove hydrogen peroxide before applying to the cultures as 
follows. α-Lipoic acid was initially dissolved at 0.5 M in DMSO and then diluted to 1 mM in 
treatment media. Lyophilized catalase (1,000 U/ml) was then added and the solution was 
incubated at 37°C for 30 min. The solution was added to growth media in the culture plates at a 
1:10 dilution, giving a final concentration of 100 µM α-lipoic acid. 
Cleavage of caspase-3 
To detect caspase-3 staining, paraformaldehyde (4%)-fixed DRG neurons were stained with 0.1 
µg/ml anti-cleaved caspase-3 (PharMingen, San Diego, CA) and 7.5 µg/ml Texas red conjugated 
goat anti-rabbit antibody (Molecular Probes, Eugene, OR) for 1 h, as described previously (7, 
18). The nuclear chromatin was counterstained with 1 µg/ml bisbenzamide in PBS. The 
specificity of the antibody was determined by immunoabsorbing against caspase-3 peptide. 
Neurons were considered to have active caspase-3 if staining can be clearly localized to the 
neuronal cytosol using fluorescence microscopy. 
Fragmentation of genomic DNA 
TdT mediated dUTP-biotin nick end labeling (TUNEL) staining was used to detect programmed 
cell death in DRG neurons. DRG neurons were fixed in 4% paraformaldehyde before staining. 
Samples were labeled with digoxygenin-dUTP and then stained with horseradish peroxidase-
conjugated anti-digoxygenin antibody using a kit according to the manufacturer’s instructions 
(Intergen, Gaithersburg, MD). 
Measurement of superoxide formation using dihydroethidium 
The cell permeant dihydroethidium (DHE; Molecular Probes) was used to assess real-time 
formation of superoxide in DRG neurons. Reduced DHE emits blue fluorescence. Exposure to 
superoxide causes oxidation to ethidium that displays red fluorescence. Stock DHE was 
dissolved at a concentration of 10 mg/ml in DMSO, diluted to 150 µM in HEPES-buffered saline 
solution (HBSS: 10 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM 
CaCl2) immediately before use, then added directly to the culture media at a 1:50 dilution, giving 
a final concentration of 3 µM. The DHE solution was applied to DRG neurons for the final 15 
min of an experiment, and then neurons were rinsed once rapidly in HBSS and immediately 
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placed in a fluorescence plate reader (Fluroskan Ascent II, Labsystems, Helsinki). For each 
sample, the ratio of red (518 nm excitation, 605 nm emission) over blue (485 excitation, 520 
emission) fluorescence was determined with 1 s integration for each reading. 
Protein concentration 
For many of the biochemical assays that follow, enzyme activity or other parameters were 
normalized to the amount of protein in the sample. The protein concentration was determined by 
the Bradford-Lowry method using the reagents and protocol supplied by Bio-Rad. Samples were 
read in a 96-well plate in an absorbance plate reader (Multiskan, Labsystems, Helsinki, Finland). 
Aconitase activity assay 
DRG neuron lysates were prepared at different times after the application of 20 mM glucose, and 
then aconitase activity was assessed by cofactor recycling using a kit according to the 
manufacturer’s protocol (Oxis Research, Bioxytech, Portland, OR). 
Thiobarbituric acid reactive substance 
Lipid peroxidation was assessed by determining the level of thiobarbituric acid reactive 
substance (TBARS) in cell lysates. DRG neurons were lysed in water, and then 100 µl sample 
was added to 200 µl ice-cold 10% trichloroacetic acid on ice for 15 min to precipitate protein. 
During this incubation, standards were prepared using 1,1,3,3-tetramethoxypropane in the range 
of 0-100 µM. Precipitated samples were centrifuged at 2,200 g for 15 min at 4°C. Supernatants 
were mixed with an equal volume of 0.67% thiobarbituric acid and then boiled for 10 min. Once 
cooled the absorbance was read at 532 nm on an absorbance plate reader (Multiskan, 
Labsystems, Helsinki, Finland). 
Assessment of 8-isosprostane F2α 
Standard Western blotting procedures were used to determine the relative levels of 8-isoprostane 
in DRG neuron lysates (19). An antibody against 8-isoprostane F2α was obtained from Cayman 
Chemical Co. (Ann Arbor, MI). This antibody detects a specific band in a gel that represents 8-
isoprostane attached in a protein complex. When cell lysates were spiked with purified 8-
isoprostane F2α, the band was increased, but the band was not detectable when 8-isoprostane 
alone was loaded on the gel (data not shown). The band was lost when the antibody was 
preabsorbed with an excess of 8-isoprostane F2α. The nitrocellulose membranes were incubated 
with 5 µg/ml primary antibody overnight at 4°C. Secondary anti-rabbit immunoglobulin antibody 
was conjugated to horseradish peroxidase diluted 1:3000 (Santa Cruz Biotechnology, Santa 
Cruz, CA) and incubated for 1 h at room temperature. Bands were visualized with enhanced 
chemiluminescence (Amersham), and exposed to film (Hyperfilm-ECI, Amersham). 
Densitometry of imaged bands was performed using NIH Image 1.6 software. Bands 
representing 8-isoprostane F2α were corrected for background and for differences in loading 
determined by probing for GAPDH. 
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Reduced glutathione  
Concentrations of reduced glutathione (GSH) were measured in cell lysates by use of a kit 
according to the manufacturer’s protocol (Cayman Chemical, Ann Arbor, MI). 
Total radical antioxidant potential 
Total radical antioxidant potential (TRAP) was determined by a luminometric method (20). DRG 
neurons were lysed in ultra-pure water and then sonicated to complete the breakdown of cellular 
structures. Lysates were centrifuged at 10,000 g for 5 min, then 5 µl of lysate was loaded on a 
96-well plate, serial doubling dilutions of a further 5 µl aliquot were also loaded in wells of the 
96-well plate; 200 µl of luminol (ECL, Amersham, Arlington Heights, IL) were added, followed 
by 50 µl of the oxidizing agent 100 mM 2,2′-azobis(amidinopropane) dihydrochloride (ABAP). 
The plate was immediately placed in a luminometric plate reader (Fluoroskan Ascent II, 
Labsystems, Helsinki, Finland) and the mean lag to the ABAP-induced oxidation of luminol that 
was attributed to the antioxidant potential of the cell lysate was measured by plotting 
luminescence against time (20). 
DRG neuron fractionation 
To assess TRAP in mitochondria and cytosol of DRG neurons, the cells were first fractionated 
by ultracentrifugation. DRG neurons were scraped off the culture surface in 10 mM 
HEPES/NaOH, pH 7.4 containing 10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml PMSF, 250 
mM sucrose, 1 mM EGTA, and 1 mM EDTA. The lysate was passed through a 28-gauge needle 
several times to shear the plasma membranes. Plasma membranes were pelleted at 1,500 g for 5 
min. The supernatant was centrifuged at 10,000 g for 15 min to pellet mitochondria. The 
mitochondrial pellet was rinsed three times to remove residual supernatant (cytosol). 
SOD activity 
The total SOD activity in cell lysates was determined using a kit according to the manufacturer’s 
protocol (Oxis Research, Bioxytech). 
Catalase activity 
Catalase activity in DRG neuron lysates was determined by assessing the ability of lysates to 
prevent hydrogen peroxide-induced oxidation of Amplex Red, per the protocol published by the 
manufacturer (Molecular Probes). 
NADH oxidase 
NADH oxidase activity in DRG neuron lysates was assessed through the rate of oxidation of 
added NADH, by measuring the absorbance at 340 nm (21). DRG neurons were scraped in 50 
mM Tris-MES buffer, pH 7.4 containing 10 µg/ml leupeptin and 10 µg/ml phenyl-methyl-
sulfonyl-fluoride (PMSF), sonicated, centrifuged at 10,000 g for 5 min, then assayed 
immediately. To inhibit NADH oxidase, diphenylene iodonium (DPI) was added to the lysate at 
a final concentration of 100 µM. 
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Statistical analysis 
All experimental samples were assayed in duplicate in each protocol. Assays were repeated on 
thee separate occasions using different DRG neuron cultures. Statistical significance was 
determined using ANOVA with 95% confidence intervals. 
RESULTS 
A short exposure to hyperglycemia is sufficient to induce programmed cell death in DRG 
neurons 
We have previously demonstrated that long-term exposure to 20 mM extra glucose produces 
mitochondrial dysfunction, oxidative stress, and initiation of programmed cell death in DRG 
neurons (7, 13). The present study was designed to further define the mechanisms that lead to 
glucose-induced DRG neuron injury. Recent studies have demonstrated that alterations in 
extracellular glucose are more detrimental to various complication-prone cell types in culture 
than a constant exposure to high glucose (22, 23). To determine the degree of DRG neuron injury 
produced by short periods of hyperglycemia, the development of caspase-3 cleavage at 6 h (Fig. 
1A) or TUNEL staining at 24 h (Fig. 1B) was compared in DRG neurons exposed to 20 mM 
added glucose for the first 2 h only or for the duration of the experiment. There were nearly 
identical levels of DRG neuron death at the end-point with a 2 h glucose exposure compared 
with prolonged hyperglycemia for the whole 6 or 24 h time course of the experiment. These 
results then led us to examine the cellular mechanisms that are activated within 2 h of 
hyperglycemia that mediate the initiation of programmed cell death. 
Hyperglycemia produces oxidative stress 
We previously demonstrated oxidative stress in DRG neurons undergoing glucose-induced 
programmed cell death (13). If oxidative stress mediates glucose-induced cell death in the DRG 
neurons, we would expect to find evidence of oxidative stress within the critical initial 2 h period 
of hyperglycemia. Therefore, early evidence of enzyme inhibition and lipid peroxidation were 
assessed in DRG neurons exposed to 20 mM added glucose. Aconitase is an enzyme in the TCA 
cycle that is exquisitely sensitive to superoxide (24). In the presence of superoxide, the critical 
Fe2+ ion is released, which reversibly inhibits the enzyme activity. Application of 20 mM added 
glucose, but not the nonmetabolizable mannitol (20 mM) significantly decreases aconitase 
activity in DRG neurons within 1 h and the activity does not recover over 5 h (Fig. 2). 
Malondialdehyde and 8-isoprostane F2α are two widely described products of ROS-mediated 
lipid peroxidation (25). The TBARS assay (Fig. 3A) measures the amount of malondialdehyde in 
cell lysates. TBARS increases significantly in DRG neurons within 1 h of the application of 20 
mM glucose. This effect is specific for glucose; the same concentration of mannitol does not 
produce an increase in TBARS. Exposure to 20 mM added glucose increases the amount of 8-
isoprostane F2α within 1 h, and this persists at 5 h in the blot compared with the loading control 
GAPDH (Fig. 3B and C). Densitometry indicates that 1 h exposure to 20 mM glucose increases 
the level of 8-isoprostane F2α threefold compared with control conditions. Again, the 
development of oxidative stress is caused by extra glucose and not through osmotic shock, since 
the effect is not reproduced by the addition of 20 mM mannitol. 
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Activation of NADH oxidase suggests that glucose-induced neuron injury occurs in the 
mitochondria 
Overloading the electron transfer chain with reduced substrates from the TCA cycle, such as 
NADH, leads to activation of the mitochondrial enzyme NADH oxidase to regenerate NAD+ (3). 
In several injury systems, activation of NADH oxidase may be the major source of superoxide 
radicals (22, 26). In DRG neurons, NADH oxidase activity increases fourfold within 1 h after the 
application of 20 mM glucose. The level of NADH oxidase activity decreases at the 3 h period, 
but a second slower peak of NADH oxidase activation is observable at the 5 h period, at a 
sevenfold higher level than baseline activity (Fig. 4A). 
We next confirmed that NADH oxidase injures DRG neurons through superoxide formation. 
DRG neuron lysates were prepared for the NADH oxidase assay, 3 µM DHE was then added, 
and the rate of DHE oxidation was assessed over several minutes. A duplicate set of samples was 
also prepared with the specific NADH oxidase inhibitor diphenylene iodonium (DPI), so that 
residual superoxide formation in these samples would be attributable to a source other than 
NADH oxidase (Fig. 4B). Two peaks of superoxide are observable at 1 and 5 h after the 
application of 20 mM glucose. The early peak of superoxide is only modestly decreased when 
NADH oxidase is inhibited, suggesting that while some NADH oxidase activity is present, a 
significant amount of superoxide is formed in the DRG neurons from a source other than NADH 
oxidase. In contrast, the slower, 5 h peak of superoxide is almost entirely abolished in the 
presence of NADH oxidase inhibition. Thus, the second peak of superoxide formation at 5 h 
following the application of 20 mM glucose is attributable to the activation of NADH oxidase. 
DRG mount an antioxidant response 
The second, 5 h peak in NADH oxidase activity led us to question whether DRG neurons 
respond to glucose-induced oxidative stress by altering other types of protein activities. More 
specifically, we examined whether DRG neurons alter antioxidant enzyme expression during 
hyperglycemia-induced oxidative stress. The ability to regulate innate antioxidant capacity may 
provide a novel therapeutic target against neuronal loss in diabetes (27). To explore the potential 
for DRG neurons to mount an antioxidant response, the activities of two antioxidant enzymes 
were examined, as well as the level of cellular reduced glutathione. The activities of total SOD, 
the enzyme that detoxifies superoxide radicals, or catalase that breaks down hydrogen peroxide 
(H2O2), were measured over the time course of glucose-induced DRG neuron injury (Fig. 5). 
Basal SOD activity in cultured DRG neurons is ~50 U/mg protein, which is relatively high 
compared with published values in nerve (Fig. 5A). After application of 20 mM glucose, there is 
a small but statistically significant increase in SOD activity at the 3 h period to 68 ± 4 U/mg 
protein that returns to baseline after 5 h. Catalase activity is moderate at baseline in the cultured 
DRG neurons with 20 ± 2 U/mg protein (Fig. 5B). Similar to SOD, catalase increases to a peak 3 
h after application of 20 mM glucose, then declines rapidly to baseline. The peak in catalase is 
highly significant, with a fivefold increase in activity over the baseline to 99 ± 5 U/mg protein. 
Reduced glutathione (GSH) was assessed in the DRG neurons at increasing times following the 
application of 20 mM glucose. Basal GSH in the cultured DRG neurons is 18.1 ± 3.0 µmol/mg 
protein (Fig. 5C). There is no rapid decrease in GSH to correspond with the early production of 
superoxide (compare with Fig. 4B). Between 1-3 h after application of 20 mM glucose, there is a 
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modest decrease in GSH to 10.8 ± 2 µmol/mg protein. There is no further change in the level of 
GSH over the remainder of the time course. This suggests that, while superoxide is generated, 
and lipid peroxides increase, the surviving DRG neurons maintain the ability to recycle GSH. 
Antioxidants prevent ROS formation and DRG neuron programmed cell death 
If rapid development of oxidative stress is a mediator of the death of DRG neurons, then 
antioxidants may protect DRG neurons during a hyperglycemic insult. α-lipoic acid is a potent 
antioxidant that may slow the progression of diabetic neuropathy in patients (28). To remove the 
H2O2 produced when α-lipoic acid was dissolved in culture media (see Materials and Methods), 
the α-lipoic acid solution was treated with catalase. Because α-lipoic acid produces H2O2 (17) 
and because catalase is unlikely to be taken up by cultured DRG neurons, application of either of 
these agents alone does not protect DRG neurons against glucose-induced injury (Fig. 6A). 
Treatment with α-lipoic acid alone is, in fact, toxic to the DRG neurons. When DRG neurons are 
treated with catalase-treated α-lipoic acid overnight (16 h) before the application of 20 mM 
glucose, the activation of caspase 3 after the application of 20 mM glucose is completely 
prevented (Fig. 6A). 
To ensure that the antioxidant treatment prevents oxidative stress, superoxide generation was 
assessed by exposing the DRG neurons to 20 mM added glucose for increasing periods of time, 
then loading with 3 µM DHE. Oxidation of DHE in intact DRG neurons was determined in a 
fluorescence plate-reader by measuring the ratio of red ethidium fluorescence to blue DHE 
fluorescence (Fig. 6B). Similar to previous studies, application of 20 mM glucose produced a 
slow rise in superoxide by 5 h. Using the sensitive fluorimetric analysis, we now observed a 
rapid transient peak in superoxide within 1 h after the glucose application. In DRG neurons that 
were pretreated for 16 h with the antioxidants α-lipoic acid plus catalase, not only the glucose-
induced peak in superoxide, but also the basal level of superoxide was significantly decreased. 
Application of 20 mM mannitol rather than glucose did not alter superoxide production at any 
time compared with untreated control DRG neurons. 
Further examination of the ability of the antioxidant treatment to prevent DRG neuron 
programmed cell death is illustrated in Fig. 6C and D with DRG neurons exposed to 20 mM 
added glucose for 24 h in the presence or absence of 16 h preincubation with catalase-treated α-
lipoic acid. Neurons are fixed and TUNEL stained. Examination of the DRG neurons by light 
microscopy reveals that 24 h after the application of 20 mM glucose there is evidence of 
condensed chromatin, nuclear DNA fragmentation (TUNEL positive) and beading of the neurites 
(Fig. 6C). These changes were completely prevented when 20 mM glucose was added in the 
presence of antioxidant pretreatment. TUNEL staining was quantitated by counting the percent 
TUNEL positive neurons in each condition (Fig. 6D). Exposure to 20 mM glucose increased 
TUNEL positivity from ~20% in untreated control cells to 78 ± 3% after 24 h. Antioxidant 
treatment alone did not alter DRG neuron survival. Pretreatment with the antioxidants 
completely prevented glucose-induced DRG neuron DNA fragmentation, with TUNEL positivity 
decreased from 78 ± 3 to 24 ± 3%. 
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Antioxidant treatment directly promotes the antioxidant potential of DRG neurons 
The rapid evidence of oxidative stress in DRG neurons, as well as the potent ability for 
exogenous antioxidants to protect against glucose-induced programmed cell death, suggests that 
these cells have little intrinsic capacity to defend against oxidative stress. Therefore, the 
antioxidant capacity of the DRG neurons was examined during the development of injury in the 
presence of 20 mM added glucose with and without antioxidant pretreatment (Fig. 7). The total 
TRAP assay measured the total capacity of a sample to prevent a chain of oxidative reactions. 
TRAP was assessed in DRG neurons over the first 5 h after the application of 20 mM glucose, 
the time course when superoxide increases (Fig. 7A). Basal TRAP in the DRG neurons was 14.5 
± 3.0 U/µg protein. Over the 5 h period, there was a trend to increase total TRAP, but this 
increase was not statistically significant. When DRG neurons were preincubated for 16 h with 
the antioxidant catalase-treated α-lipoic acid, total TRAP increased from 14.5 ± 3 U/µg protein to 
42.9 ± 2 U/µg protein. There was no significant change in TRAP over the time course after 
application of 20 mM glucose in the antioxidant-treated DRG neurons. 
Despite evidence that there was a modest increase in SOD and catalase and only a small decrease 
in GSH, the fact that the total antioxidant potential did not decrease in the presence of glucose-
induced oxidative stress was surprising. Since the injurious oxidative stress after hyperglycemia 
is hypothesized to occur in the mitochondria, the DRG neurons were fractionated by 
ultracentrifugation, and then TRAP was assessed in the mitochondrial and cytosolic fractions. 
This assay requires a large number of cells per condition, so we chose to limit our experiments to 
a 3 h time course (Fig. 7B). Separation of mitochondria and cytosol was demonstrated by 
Western blotting for the mitochondrial marker COX-IV and the cytosolic marker lactate 
dehydrogenase (not shown). The increase in TRAP was observed in the cytosolic fraction and 
was more marked than the increase in TRAP in the whole cell lysate. In contrast, TRAP in the 
mitochondrial fraction decreased by the 3 h period, suggesting that exposure to hyperglycemia 
that injures DRG neurons can specifically produce oxidative stress in the mitochondria. Thus, it 
is likely the prevention of this mitochondrial oxidative stress through the pretreatment with 
catalase-treated α-lipoic acid protects DRG neurons against hyperglycemia-induced cell death. 
DISCUSSION 
These studies in DRG neurons provide compelling evidence that acute hyperglycemic episodes 
can cause neuronal cell death through a mechanism that involves oxidative stress in the 
mitochondria. Notably, a 2 h period of exposure to 20 mM added glucose is as severe as 24 h, 
producing equal levels of DRG neuron death. In clinical diabetes, transient peaks of 
hyperglycemia underlie the early development of microvascular complications and present a 
significant challenge to both the patient and physician (29, 30). The continual tight control of 
blood glucose is the most effective means of preventing diabetic complications (6). In parallel, in 
cell culture, periodic fluctuations in glucose are more detrimental to cells than constant exposure 
to increased glucose levels, as observed in large vein endothelial cells (22), mesangial cells (31), 
and tubulointerstitial cells (23). Although our work is focused on DRG neurons, our findings 
may have broader application to an increased understanding of diabetic macrovascular disease, 
nephropathy, and retinopathy (32, 33). 
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By comparing the timelines for changes in enzyme systems, oxidative stress, and evidence of 
programmed cell death in cell culture (Fig. 8), we can propose a mechanism for increasing injury 
by fluctuating glucose levels. In DRG neurons, the switch to high glucose rapidly produces 
oxidative stress that can injure neurons within 2 h, probably through mitochondrial stress (3, 13). 
Yet, the neurons rapidly adapt through feedback mechanisms on these metabolic pathways, loss 
of aconitase, and rapid increases in antioxidant enzyme activity. Remaining at high glucose 
levels, then, would not produce additional stress on the cells, as they have adapted to the high 
glucose insult. However, a return to low glucose would promote the restoration of the glycolytic 
pathway and a decrease in the antioxidant enzymes so that another switch to high glucose will 
produce a second burst of oxidative stress and thus a greater accumulated injury. 
If oxidative stress mediates the induction of DRG neuron injury, then we should find evidence of 
oxidative stress within the critical 2 h period of hyperglycemia that leads to cell death. In the 
current study, aconitase activity was rapidly and irreversibly lost within 1 h after the application 
of 20 mM glucose but not mannitol. This suggests that hyperglycemia-induced superoxide 
generation rapidly inhibits the TCA cycle and that this is a metabolic effect unrelated to osmotic 
stress. There is some evidence that aconitase is decreased in animal models of diabetes (34), but 
this enzyme is not widely studied in vivo, probably because it is difficult to extract intact. 
Lipid peroxidation is a widely used biomarker of cellular oxidative stress (19). Many clinical and 
in vivo animal models of diabetes use the TBARS assay to determine lipid peroxidation in tissue 
and biological fluids (reviewed in ref 27). There are no published data on TBARS on cell culture 
models of hyperglycemia, although lipid peroxidation is documented in glucose-exposed ex vivo 
nerve tissue (35) and in cultures exposed to AGEs (36). In animal models, TBARS is elevated 
after 6 wk of diabetes in the small intestine (37), brain (38), liver, and pancreas (39). Plasma 
TBARS is elevated in diabetic patients (40). Thus the current data showing a steady rise in 
TBARS following the application of 20 mM glucose is consistent with the concept that 
hyperglycemia produces lipid peroxidation in DRG neurons that could contribute to neuropathy. 
The data also confirm that oxidative stress is present within the first critical 2 h period of 
hyperglycemia. 
Our data implicate NADH oxidase in the sustained production of superoxide in DRG neurons 
exposed to elevated glucose. This enzyme is involved in hyperglycemia-induced macrovascular 
disease (22) and diabetic nephropathy (26) through the generation of superoxide. NADH oxidase 
also contributes to microvascular deficits in diabetic rats and inhibition of the enzyme 
significantly improves nerve blood flow after 6 wk of diabetes (41). Although the NAD+:NADH 
ratio is unbalanced in the nerve of diabetic rats (42), few studies have directly explored the role 
of NADH oxidase in the pathogenesis of diabetic neuropathy. Taken together, these data suggest 
that NADH oxidase could be an important therapeutic target in the treatment of diabetic 
neuropathy. 
The early increase in cytosolic TRAP, with a concomitant decrease in mitochondrial TRAP, 
suggests that mitochondria are key sites of glucose-mediated injury. Although DRG neurons 
increase cytosolic antioxidant enzymes, this increase is insufficient to prevent injury. Our data 
suggest that the mitochondria are less able to prevent glucose-induced oxidative stress, probably 
because this is the main site for free radical generation in hyperglycemia (13, 43). Thus, 
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mitochondrial stress is likely to produce hyperglycemia-induced DRG neuron death and 
consequently provides an intracellular target for antioxidant therapy. 
Another means of preventing neuropathy through glucose-mediated oxidative stress may involve 
manipulation of the innate antioxidant response of the cells. The present study demonstrates a 
modest increase in cytosolic antioxidant potential in the presence of hyperglycemia that is 
insufficient, and probably too late, to prevent neuron death. We also demonstrate an increase, 
again albeit late as well as transient, in the antioxidant enzymes SOD and catalase in these cells. 
Changes in antioxidant enzymes have been widely studied in diabetic rats, although the data are 
conflicting. Generally, SOD increases in diabetic animals in the liver (39, 44). Kidney SOD 
increases in some studies (45) but decreases in others (39). In the brain and heart, SOD activity 
decreases (46, 47). In contrast, catalase is decreased in most diabetic tissues (47). The current 
study may help to explain the variable SOD results observed in animal models of diabetes. The 
DRG neurons may have a higher steady state of SOD activity in the pro-oxidant culture system 
than is reported in vivo (see Fig. 5A and ref 48), but they retain the ability to respond to a 
hyperglycemic insult. Thus, even in nontreated diabetic rats, SOD activity is likely to rapidly 
alter with eating and with other stress cues. 
The innate ability of cells to activate an oxidative stress response is an area of intense research 
activity (49). Small molecule mediators that promote antioxidant status directly in neurons may 
provide an exciting new avenue for therapy against diabetic neuropathy. SOD mimetics are 
under investigation in diabetes complications and so far, these have been found effective against 
hyperglycemia-induced apoptosis in the retina (27). 
Since these therapies targeting the innate oxidative stress response are early in development, 
exogenous antioxidants remain the most promising avenue for the prevention of diabetic 
neuropathy (1, 27). Consistent with many other studies we demonstrate that antioxidants can 
potently prevent hyperglycemia-induced oxidative stress and cell death in culture (50). Studies of 
α-lipoic acid in animal and cell culture models demonstrate decreases in both oxidative stress 
and in diabetes-induced changes in endogenous antioxidant systems (35, 39, 47). The 
understanding that antioxidants may prevent complications has led to the broad use of α-lipoic 
acid in diabetic patients in Europe (16). An additional benefit of α-lipoic acid for type 2 diabetes 
is its ability to promote insulin sensitivity (51, 52). 
The maintenance of nondiabetic levels of SOD and catalase in the presence of exogenous 
antioxidants is particularly interesting. This is most likely explained by the large increase in 
TRAP that we observe in the presence of α-lipoic acid and catalase treatment that would blunt 
the cellular response to free radical generation. The clinical implication of these findings is that 
combined therapies that directly boost the innate antioxidant enzyme systems as well as supply 
increased cellular antioxidant potential will provide superior protection against peaks of 
oxidative stress during periods of hyperglycemia. 
Our demonstration that a brief, 2 h, exposure to hyperglycemia is sufficient to produce 
significant cell death in DRG neurons is consistent with accumulating clinical data. Some degree 
of neuropathy is eventually diagnosed in >50% of diabetic patients and only intensive glycemia 
control is known to decrease this incidence (6). Often, painful diabetic neuropathy is the 
presenting symptom for type 2 diabetes (53), and patients with impaired glucose tolerance 
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develop neuropathy that cannot be attributed to other metabolic impairments (29). While our in 
vitro model produces a very acute injury, we note that clinical diabetes can take years to develop. 
This difference can be explained by considering that the in vivo system is more complex than the 
more homogeneous cell population obtained after 3 days in culture. In culture all the cells are 
simultaneously exposed to the insult. In vivo, we expect fewer cells to be exposed to the acute 
insult through spatial separation. In addition, our system does not consider the possibility that 
neurons can regenerate (54). Even in the culture system, we never kill all of the neurons, and we 
cannot extrapolate this reduction in numbers of cell bodies to predict when clinical symptoms in 
man will occur. Despite this difference between our in vitro model and clinical or experimental 
diabetes, we have identified many parallel changes in oxidative stress and antioxidant systems. 
This study has prompted ongoing efforts to develop new mouse models of diabetes 
complications through neuronal specific manipulations of antioxidant enzymes such as SOD and 
glutathione synthetases. At present, we are breeding mice with Cre-linked promoters for 
neuronal nestin with mice that have lox-linked target antioxidant enzymes. 
In summary, oxidative stress is a critical target for therapeutic intervention in diabetic 
neuropathy and impaired glucose tolerance. Both increasing the nerve expression of antioxidant 
enzymes and the application of antioxidants will be beneficial. In addition, inhibition of 
superoxide-producing enzymes such as NADH oxidase may be another important therapeutic 
target. Combining these approaches will provide a new avenue of therapy for patients with 
neuropathy due to diabetes and impaired glucose tolerance. 
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Fig. 1 
 
                                          
 
Figure 1. A 2 h exposure to hyperglycemia is sufficient to induce DRG neuron cell death. Glucose (20 
mM) was added to DRG neurons and either removed after 2 h or left for the duration of the experiment. In A, 
DRG neurons were fixed after 6 h and stained for cleaved caspase-3. In B, DRG neurons were fixed after 24 h 
and TUNEL stained. There is no difference in caspase-3 cleavage between 2 or 6 h hyperglycemia. Similarly, 
there is no difference in TUNEL positivity between 2 or 24 h hyperglycemia. 
 
Page 17 of 24





Figure 2. Aconitase is rapidly inhibited by hyperglycemia in DRG neurons. Aconitase activity was measured in DRG 
neurons over time after application of 20 mM glucose or 20 mM mannitol as an osmotic control. *Aconitase activity is 
significantly decreased compared with untreated control cells within 1 h and continues to decrease over 5 h, P < 0.01. 
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Fig. 3 
 
                                                   
 
Figure 3. Lipid peroxidation increases within 1 h after hyperglycemia in DRG neurons.  A) TBARS assay 
demonstrates that MDA increases significantly within 1 h of adding 20 mM glucose compared with untreated control 
cultures, P < 0.05. TBARS continues to increase significantly between 1-3 and 3-5 h, P < 0.05. In contrast, 20 mM 
mannitol does not alter TBARS in DRG neurons. B) Comparison of 8-isoprostane F2α in untreated control cultures with 1 
or 6 h exposure to 20 mM glucose demonstrates a significant increase within 1 h that remains elevated at 6 h. This effect is 
not present with mannitol treatment. Membranes were reprobed with GAPDH as a loading control. C) Blot illustrated in B 
is analyzed by densitometry. Corrected mean pixel density for 1 h exposure to 20 mM glucose is 3-fold higher than in 
control (P<0.001). At 5 h after the application of 20 mM glucose, 8-isoprostane F2α remains higher than control (P<0.05). 
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Fig. 4 
 
                            
 
Figure 4. NADH oxidase is activated after hyperglycemia in DRG neurons. A) NADH oxidase actively is measured in 
DRG neurons over time after application of 20 mM glucose. Two peaks of activity are observed at 1 h and 5 h that are 
significantly higher than untreated control neurons (P<0.01). B) The same lysates were assayed for NADH oxidase in the 
presence of DHE to assess superoxide production by the enzyme. Two peaks of superoxide are also observed on a similar 
time-frame but with different magnitudes of induction. The 1 h peak in NADH oxidase activity is a 5-fold increase, but the 
increase in DHE oxidation is 9-fold. The NADH oxidase inhibitor DPI (100 µM) partially blocks 1 h peak in superoxide 
but almost completely blocks superoxide at 5 h. 
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Fig. 5 
 
                                                     
 
Figure 5. Antioxidant enzyme systems increase in response to acute hyperglycemia. DRG neurons were lysed after 
increasing periods of exposure to 20 mM added glucose. Lysates were assessed for SOD activity (A), catalase activity (B), 
and concentration of reduced glutathione (GSH; C). *SOD was significantly elevated at the 3 h time point only compared 
with untreated control neurons (P<0.05). +Catalase was significantly elevated also at 3 h time point only compared with 
untreated control neurons (P<0.01). GSH decreased moderately over time course examined (*P<0.05). 
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Fig. 6 
 
                                                                                         
Figure 6. Exogenous antioxidants prevent glucose-induced oxidative stress and programmed cell death in cultured 
DRG neurons. A) Glucose-induced activation of caspase-3 was assessed by immunohistochemistry in the presence of α-
lipoic acid (100 µM) or catalase (100 U/ml) or both. *Glucose or α-lipoic acid not treated with catalase significantly 
increased caspase-3 activation, P < 0.001. B) Superoxide formation in intact DRG neurons was assessed by loading with 
DHE (3 µM). Effects of glucose (20 mM) alone, glucose plus α-lipoic acid (100 µM) and catalase (100 U/ml) (glucose + 
antiox), and mannitol (20 mM) on DHE oxidation were determined up to 5 h. +Antioxidant treatment prevents both 
glucose-induced increases and basal levels of superoxide generation at 0, 1, 2, and 4 h. Mannitol does not alter superoxide 
generation in the DRG neurons. C) Programmed cell death evidenced by DNA fragmentation (TUNEL assay) was 
determined in DRG neurons 24 h after glucose treatment ± antioxidant treatment. The increase in TUNEL positivity 
(brown nuclei) by glucose was prevented in the presence of catalase-treated α-lipoic acid. Evidence of condensed 
chromatin (arrowhead) and beading of neurites (arrow) also suggest that glucose-induced cell death involves programmed 
cell death. D) Quantitation of the TUNEL staining in C demonstrates that glucose significantly increases DNA 
fragmentation in DRG neurons (P<0.001), but application of catalase-treated α-lipoic acid (Antiox) completely prevents 
glucose-induced programmed cell death. 
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Fig. 7 
 
                                   
                                                                                            
Figure 7. Total radical antioxidant potential (TRAP) is not decreased during acute hyperglycemia in DRG 
neurons. A) Whole DRG neuron lysates were assessed for the ability to prevent ABAP-induced oxidation of luminol at 
increasing periods after the application of 20 mM glucose. Pretreatment with antioxidant combination of catalase-treated 
(100 U/ml) α-lipoic acid (100 µM) increased basal TRAP 3-fold. Over the time course of application of 20 mM glucose, 
TRAP slightly increased in the presence and absence of the antioxidants. B) DRG neurons were separated into 
mitochondrial or cytosolic fractions by ultracentrifugation before TRAP assay. A differential effect of glucose application 
is seen in these 2 fractions, although the results do not reach statistical significance. 
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Figure 8. Time course of oxidative stress, antioxidant response, and cell death in DRG neurons treated with high 
glucose. By comparing time lines of experiments described in this study, we observe that the 2 h period of hyperglycemia 
that is sufficient to induce DRG neuron death is associated with superoxide generation, early lipid peroxidation, and loss of 
aconitase activity. Antioxidant enzymes increase at a later time (3 h), and evidence of programmed cell death reaches 
significance even later at 4-6 h (7). Thus, it is rapid hyperglycemia-induced acute oxidative stress that leads to DRG neuron 
death. 
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